Researchers with the University of Pennsylvania have good news for people who have multiple sclerosis and are taking anti-CD20 treatment — though their antibody response triggered by the vaccine may be low, their bodies are still able to produce “robust T-cell responses” against the SARS-CoV-2 virus. As a result, the researchers say MS patients receiving the anti-CD20 treatment should still …
COVID-19 vaccine study has good news for people with multiple sclerosis
Slash Gear - 17 Sep 2021 01:19
Researchers with the University of Pennsylvania have good news for people who have multiple sclerosis and are taking anti-CD20 treatment — though their antibody response triggered by the vaccine may be low, their bodies are still able to produce “robust T-cell responses” against the SARS-CoV-2 virus. As a result, the researchers say MS patients receiving the anti-CD20 treatment should still …
Share this Article
Recommended